In mu10, the enriched term ‘pathways in cancer’ is mapped to several known genes of special importance, such as Vegf, Vegfr2, Glut1, Egf, Fdgr, Pi3k, Fak, Foxo1, p21, and Myc. Similarly, in mu3, and mu6, a group of proto-oncogenes is significantly enriched. This evidence concerns the gene SLC2A1 and cancer.